Literature DB >> 19754881

The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds.

Sean A Hudson1, Heath Ecroyd, Tak W Kee, John A Carver.   

Abstract

Thioflavin T (ThT) dye fluorescence is used regularly to quantify the formation and inhibition of amyloid fibrils in the presence of anti-amyloidogenic compounds such as polyphenols. However, in this study, it was shown, using three polyphenolics (curcumin, quercetin and resveratrol), that ThT fluorescence should be used with caution in the presence of such exogenous compounds. The strong absorptive and fluorescent properties of quercetin and curcumin were found to significantly bias the ThT fluorescence readings in both in situ real-time ThT assays and single time-point dilution ThT-type assays. The presence of curcumin at concentrations as low as 0.01 and 1 mum was sufficient to interfere with the ThT fluorescence associated with fibrillar amyloid-beta(1-42) (0.5 mum) and fibrillar reduced and carboxymethylated kappa-casein (50 mum), respectively. The ThT fluorescence associated with fibrillar amyloid-beta(1-42) was also biased using higher concentrations of resveratrol, a polyphenol that is not spectroscopically active at the wavelengths of ThT fluorescence, implying that there can be direct interactions between ThT and the exogenous compound and/or competitive binding with ThT for the fibrils. Thus, in all cases where ThT is used in the presence of an exogenous compound, biases for amyloid-associated ThT fluorescence should be tested, regardless of whether the additive is spectroscopically active. Simple methods to conduct these tests were described. The Congo red spectral shift assay is demonstrated as a more viable spectrophotometric alternative to ThT, but allied methods, such as transmission electron microscopy, should also be used to assess fibril formation independently of dye-based assays. Structured digital abstract: * MINT-7259867: RCMkappa-CN (uniprotkb:P02668) and RCMkappa-CN (uniprotkb:P02668) bind (MI:0407) by electron microscopy (MI:0040) * MINT-7258930: RCMkappa-CN (uniprotkb:P02668) and RCMkappa-CN (uniprotkb:P02668) bind (MI:0407) by fluorescence technologies (MI:0051) * MINT-7259878: Amyloid beta (uniprotkb:P05067) and Amyloid beta (uniprotkb:P05067) bind (MI:0407) by fluorescence technologies (MI:0051).

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19754881     DOI: 10.1111/j.1742-4658.2009.07307.x

Source DB:  PubMed          Journal:  FEBS J        ISSN: 1742-464X            Impact factor:   5.542


  111 in total

1.  Role of zinc in human islet amyloid polypeptide aggregation.

Authors:  Jeffrey R Brender; Kevin Hartman; Ravi Prakash Reddy Nanga; Nataliya Popovych; Roberto de la Salud Bea; Subramanian Vivekanandan; E Neil G Marsh; Ayyalusamy Ramamoorthy
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

2.  Analysis of the inhibition and remodeling of islet amyloid polypeptide amyloid fibers by flavanols.

Authors:  Ping Cao; Daniel P Raleigh
Journal:  Biochemistry       Date:  2012-03-21       Impact factor: 3.162

3.  Response surface methodology for optimizing the bovine serum albumin fibrillation.

Authors:  Amir Arasteh; Mehran Habibi-Rezaei; Azadeh Ebrahim-Habibi; Ali Akbar Moosavi-Movahedi
Journal:  Protein J       Date:  2012-08       Impact factor: 2.371

4.  Rationally designed peptoids modulate aggregation of amyloid-beta 40.

Authors:  J Phillip Turner; Tammy Lutz-Rechtin; Kelly A Moore; Lauren Rogers; Omkar Bhave; Melissa A Moss; Shannon L Servoss
Journal:  ACS Chem Neurosci       Date:  2014-04-16       Impact factor: 4.418

5.  Cannabinoid effects on β amyloid fibril and aggregate formation, neuronal and microglial-activated neurotoxicity in vitro.

Authors:  Emelie Janefjord; Jesper L V Mååg; Benjamin S Harvey; Scott D Smid
Journal:  Cell Mol Neurobiol       Date:  2013-09-13       Impact factor: 5.046

6.  Discovery and structure activity relationship of small molecule inhibitors of toxic β-amyloid-42 fibril formation.

Authors:  Heiko Kroth; Annalisa Ansaloni; Yvan Varisco; Asad Jan; Nampally Sreenivasachary; Nasrollah Rezaei-Ghaleh; Valérie Giriens; Sophie Lohmann; María Pilar López-Deber; Oskar Adolfsson; Maria Pihlgren; Paolo Paganetti; Wolfgang Froestl; Luitgard Nagel-Steger; Dieter Willbold; Thomas Schrader; Markus Zweckstetter; Andrea Pfeifer; Hilal A Lashuel; Andreas Muhs
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

7.  Evolutionary Adaptation and Amyloid Formation: Does the Reduced Amyloidogenicity and Cytotoxicity of Ursine Amylin Contribute to the Metabolic Adaption of Bears and Polar Bears?

Authors:  Rehana Akter; Andisheh Abedini; Zachary Ridgway; Xiaoxue Zhang; Joel Kleinberg; Ann Marie Schmidt; Daniel P Raleigh
Journal:  Isr J Chem       Date:  2016-12-19       Impact factor: 3.333

8.  A Robust and Scalable High-Throughput Compatible Assay for Screening Amyloid-β-Binding Compounds.

Authors:  Richard McClure; Rey Redha; Paige Vinson; Wellington Pham
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

9.  Conformational-Sensitive Fast Photochemical Oxidation of Proteins and Mass Spectrometry Characterize Amyloid Beta 1-42 Aggregation.

Authors:  Ke Sherry Li; Don L Rempel; Michael L Gross
Journal:  J Am Chem Soc       Date:  2016-09-12       Impact factor: 15.419

10.  Amyloid-β-neuropeptide interactions assessed by ion mobility-mass spectrometry.

Authors:  Molly T Soper; Alaina S DeToma; Suk-Joon Hyung; Mi Hee Lim; Brandon T Ruotolo
Journal:  Phys Chem Chem Phys       Date:  2013-04-24       Impact factor: 3.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.